PR Newswire BiotechOriginal article
Phase III MAVERICK Trial Supports Brain MRI Surveillance Alone as Standard of Care for Small-Cell Lung Cancer
Phase 3positivePositive
AI Analysis
Summary
Phase III SWOG S1827 MAVERICK trial demonstrated that MRI surveillance alone, without prophylactic cranial irradiation, improved cognitive failure-free survival and reduced serious treatment-related adverse events in small-cell lung cancer patients.
Clinical Trial Data
Phase
Phase III
Primary Endpoint
Met
Outcome Details
MRI surveillance without prophylactic cranial irradiation improved cognitive failure-free survival and substantially reduced serious treatment-related adverse events
Importance:7/10
Sentiment:
0.80
Phase 3MAVERICK trialSWOG S1827small-cell lung cancerbrain MRIclinical trial results
Read the original article
Published by PR Newswire Biotech on September 13, 2026 12:54 PM